Q3 2025 Earnings Call October 23, 2025 9:30 AM EDTCompany ParticipantsGregory Bardi - Vice President of Investor ...
Netherlands-based argenx has published positive topline results from its ADAPT SERON trial of its market-leading drug for generalised myasthenia gravis (gMG) Vyvgart (efgartigimod). Significantly, the ...
It was once more a day dominated by diplomacy as Donald Trump's team looked to shore up the US-brokered ceasefire agreement that came under strain over the weekend. Israel was meanwhile served with a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback